Usage and Plan of Care Changes Due to Drug Screenings

Data Collection Analysis Business Management

Status: Unknown

Conditions: Pain Management

Treatments: Other: Does not include a drug needing FDA approval and therefore it is not by definition, a Clinical Drug Trial as defined by FDA.

Study type: Observational

Funder types: Other

Identifiers

NCT02995278

PAS1459

Details and patient eligibility

About

The purpose of this minimal risk, observational survey is to document the accuracy, benefits, and how qualitative and quantitative results affect patients' plan of care.

Full description

Pain is the most common reason patients consult primary care providers. According to recent surveys, One in six Americans live with chronic or recurrent pain and pay an estimated $120 billion a year in medical costs in the United States. Oral opioids are the common treatment options for various chronic pains including joint pain, musculoskeletal pain, neuropathic pain and migraines. This narcotic-based management of pain is often associated with undesirable side effects with addictive and potential abuse.

To ensure proper usage of prescribed medications, physicians use drug screens to monitor therapeutic levels and test for presence of illegal drugs or medications that may cause a drug-drug interaction. Upon receiving quantitative or qualitative results from these drug screens, the physician may change the treatment plan for patients to improve efficacy of prescribed medications.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 64 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be a Medical Practioner

  • Medical Doctor (MD)
  • Doctor of Osteopathic (DO)
  • Physician Assistant (PA)
  • Advanced Practice Registered Nurse (APRN)
  • Nurse Practioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion criteria

• Government-funded insurance data cannot be included in the study.